IPO

Zenith Drugs Limited IPO

NSE SME

Listed On: Feb 27, 2024 at ₹ 110.0

₹ 126400 /1600 Shares

Check Allotment
Zenith Drugs Limited IPO Details

19 Feb, 2024

Open Date

22 Feb, 2024

Close Date

23 Feb, 2024

Allotment Date

27 Feb, 2024

Listing Date

Issue Price

₹75-79 per equity share

Face Value

₹10 Per Equity Share

Listing at Group

NSE SME

Registrar

Bigshare Services Pvt Ltd

List Price

110.0

Listing Date

2024-02-27

Market Lot

1600 Shares (₹126,400/-)

Lead Manager

Gretex Corporate Services Limited

Issue Size

5,148,800 shares(aggregating up to ₹40.68 Cr)

Retail Portion

35%

Subscription

179.07 times

IPO Docs

DRHP RHP

Zenith Drugs Limited IPO Details


Zenith Drugs Limited IPO is an SME IPO, priced at ₹75-79 per equity share. The equity shares have a face value of ₹10 Per Equity Share each and will be listed on the NSE SME platform. The IPO comprises a total issue of 51,48,800 equity shares, aggregating up to ₹40.68 crores..

The IPO bidding window is open from Feb 19, 2024 to Feb 22, 2024. The allotment is expected to be finalized on Feb 23, 2024, and the tentative listing date is Feb 27, 2024.

The minimum lot size for retail investors is 1600 shares, with a minimum investment of ₹1,26,400. For HNIs, the minimum application size is 2 lots , amounting to ₹ 2,52,800.

Gretex Corporate Services Limited is acting as the lead manager to the issue. The registrar of the IPO is Bigshare Services Pvt Ltd, and Gretex Share Broking Private Limited will act as the market maker for this issue.

Read More

Zenith Drugs Limited IPO Subscription Details

As onQIB / NIIRetailTotal
Shares Offered / Reserved859,200 / 644,8001,504,0003,008,000
Day 1 - 19-02-24 06:00 PM0.00 / 0.99 x3.42 x1.92 x
Day 2 - 20-02-24 06:00 PM3.53 / 2.50 x9.41 x6.25 x
Day 3 - 21-02-24 06:00 PM3.54 / 7.98 x19.42 x12.43 x
Day 4 - 22-02-24 06:00 PM106.72 / 369.94 x138.57 x179.07 x
Total No. of Applications: 1,30,900 (Approx)

Zenith Drugs Limited Valuations

EPS Pre IPO

₹4.29/-

EPS Post IPO

₹6.29/-

P/E Pre IPO

18.4

P/E Post IPO

12.56

ROE

35.13%

ROCE

37.29%

Debt/Equity

1.51

RoNW

29.88%

Price to Book Value

5.50

Zenith Drugs Limited Company Financials All values are in ₹ Lakh

30-Sep-2331-Mar-2331-Mar-22
Assets11,249.049,793.836,858.47
Revenue6,948.4311,569.659,266.63
Profit After Tax539.38515.29312.86
Net Worth2,264.961,724.421,209.09
Reserves & Surplus1,064.961,684.421,169.09
Total Borrowing2,902.812,605.031,880.86

About The Company

Zenith Drugs Limited is a pharma company which was incorporated in the year 2000. Its products include medicines that are highly quality and are sold at relatively low prices in the market as well as generics.

The organization complies with WHO-GMP and has got ISO 9001:2015 certification issued by EuroUK recognized certification body.

Product portfolio comprises of:
ORS Powder
Liquid Orals
Ointments;
Liquid Externals; and
Capsules

The Food & Drugs Administration has certified more than 600 products from the company that are being put into production 325 in stock.The establishment of a manufacturing facility in an area known as Village Muradpura at Depalpur, Indore, Madhya Pradesh is under operation.

The company sells its products to countries in Central America and the Caribbean and Pacific regions, Malawi, Mauritius, Mozambique, Sudan, Tanzania, Bhutan, Cambodia in Southeast Asia, Tajikistan, Liberia, Sierra Leone, and Conakry.Zenith Drugs Limited is into third-party manufacturing, or white label manufacturing, for respected pharmaceutical companies like Ajanta Pharma, Bio Medical Laboratories, and Zest Pharma, among others.

As of 31 March, 2023, there were 89 staff; 61 of them were payroll employees while the rest are 28 are contractual.

Read More

Zenith Drugs Limited - Promoter(s)

Pre Issue Share Holding: 100%

Post Issue Share Holding: 69.68%

Company Promoter(s)
  1. Mr. Sandeep Bhardwaj
  2. Mr. Bhupesh Soni
  3. Mr. Ajay Singh Dassundi

Zenith Drugs Limited IPO - Issue Objectives

  1. Purchase of Machinery & Equipments for Setting up New Unit
  2. Existing Manufacturing Block Upgradation
  3. Working Capital Requirements
  4. General Corporate Purposes.

Other Details

Company Contact Details

Zenith Drugs Limited

K. No. 72 / 5, Village Muradpura, NA Depalpur, Indore-453001

Phone: +91 8435501867

Email: info@zenithdrugs.com

Website: https://zenithdrugs.com/

Zenith Drugs Limited IPO - FAQs

Ans. Zenith Drugs Limited IPO is a SME IPO. The issue is priced at ₹75-79 per equity share. The minimum order quantity is 1600 Shares. The IPO opens on Feb 19, 2024, and closes on Feb 22, 2024. Bigshare Services Pvt Ltd is the registrar for the IPO. The shares are proposed to be listed on NSE SME.

Ans. The Zenith Drugs Limited IPO opens on Feb 19, 2024 and closes on Feb 22, 2024.

Ans. The size of Zenith Drugs Limited IPO is 5,148,800 shares(aggregating up to ₹40.68 Cr).

Ans. The IPO price band is set between ₹75-79 per equity share.

Ans. To apply for Zenith Drugs Limited IPO IPO, follow the steps given below:

  • - Open the IPO Ji App or Website
  • - Find Zenith Drugs Limited IPO in the List of IPOs
  • - Press "Apply" Button
  • - Select Your Demat Account
  • - Select Your Shares Quantity and Submit
  • - Track Your IPO Status

Ans. The share allotment date of Zenith Drugs Limited IPO is Feb 23, 2024.

Ans. The Zenith Drugs Limited IPO will be listed on Feb 27, 2024.

Ans. Follow the steps to check the allotment status for Zenith Drugs Limited IPO here.